PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 88818199 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 127 |
MARK SECTION | |
MARK | PROLANZA (see, http://uspto.report/TM/88818199/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | PROLANZA |
OWNER SECTION ( 1st owner)(current) | |
NAME | LAILA NUTRACEUTICALS |
INTERNAL ADDRESS | 40-15-14 Brindavan Colony, Labbipet |
MAILING ADDRESS | Vijayawada |
CITY | Andhra Pradesh |
ZIP/POSTAL CODE | 520010 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | India |
XXXX | |
OWNER SECTION ( 1st owner) (proposed) | |
NAME | LAILA NUTRACEUTICALS |
INTERNAL ADDRESS | 40-15-14 Brindavan Colony, Labbipet |
MAILING ADDRESS | Vijayawada |
CITY | Andhra Pradesh |
ZIP/POSTAL CODE | 520010 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | India |
XXXX | |
OWNER SECTION ( 2nd owner)(current) | |
NAME | Inventia Healthcare Limited |
INTERNAL ADDRESS | Unit 703, 704, 7th Flr, Hubtown Solaris |
MAILING ADDRESS | N S Phadke Marg, Andheri (East) |
CITY | Mumbai |
ZIP/POSTAL CODE | 400069 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | India |
XXXX | |
OWNER SECTION ( 2nd owner) (proposed) | |
NAME | Inventia Healthcare Limited |
INTERNAL ADDRESS | Unit 703, 704, 7th Flr, Hubtown Solaris |
MAILING ADDRESS | N S Phadke Marg, Andheri (East) |
CITY | Mumbai |
ZIP/POSTAL CODE | 400069 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | India |
XXXX | |
OWNER SECTION ( 3rd owner)(current) | |
NAME | NattoPharma ASA |
MAILING ADDRESS | Lilleakerveien 2B |
CITY | Oslo |
ZIP/POSTAL CODE | 0283 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Norway |
XXXX | |
OWNER SECTION ( 3rd owner) (proposed) | |
NAME | NattoPharma ASA |
MAILING ADDRESS | Lilleakerveien 2B |
CITY | Oslo |
ZIP/POSTAL CODE | 0283 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Norway |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | Mark David Torche |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@patwrite.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | melissa@patwrite.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Mark David Torche |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@patwrite.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | melissa@patwrite.com; mtorche@gmail.com |
DOCKET/REFERENCE NUMBER | 1801235-010 |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Ashwagandha sold as an integral component of nutritional supplements, dietary supplements, mineral supplements, herbal supplements, and vitamin supplements for use in foods, beverages and cosmetics |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 05/11/2021 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /mark david torche/ |
SIGNATORY'S NAME | Mark David Torche |
SIGNATORY'S POSITION | Attorney of record, New York Bar member |
DATE SIGNED | 11/09/2021 |
SIGNATORY'S PHONE NUMBER | 641-753-3995 |
SIGNATURE METHOD | Signed directly within the form |
FILING INFORMATION | |
SUBMIT DATE | Tue Nov 09 12:16:05 ET 2021 |
TEAS STAMP | USPTO/ESU-XXX.XX.XXX.XXX- 20211109121605379749-8881 8199-781ffc67cb65258b64c7 d824327f187c57e238ddae0fe 12e98a324995fe579974-ET-1 6032318-20211109121134931 813 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |